ABIVAX S.A. Share Price Today: Live Updates & Key Insights

ABIVAX S.A. share price today is $117.43, up -2.18%. The stock opened at $123.89 against the previous close of $123.025, with an intraday high of $126.73 and low of $120.11.

ABIVAX S.A. Share Price Chart

ABIVAX S.A.

us-stock
To Invest in {{usstockname}}
us-stock

ABIVAX S.A. Share Price Performance

$117.43 -0.0218(-2.18%) ABVX at 23 Mar 2026 11:52 AM Biotechnology
Lowest Today 120.11
Highest Today 126.73
Today’s Open 123.89
Prev. Close 123.025
52 Week High 148.83
52 Week Low 4.77
Day’s Range: Low 120.11 High 126.73
52-Week Range: Low 4.77 High 148.83
1 day return -
1 Week return -1.96
1 month return -9.43
3 month return -13.31
6 month return +46.23
1 year return +1541.77
3 year return +1331.66
5 year return -
10 year return -

ABIVAX S.A. Institutional Holdings

ABIVAX S.A. Market Status

Strong Buy: 4

Buy: 2

Hold: 1

Sell: 0

Strong Sell: 0

ABIVAX S.A. Fundamentals

Market Cap 8187.96 M

PB Ratio 16.5049

PE Ratio 0.0

Enterprise Value 8996.32 M

Total Assets 205.23 M

Volume 1379997

ABIVAX S.A. Company Financials

Annual Revenue FY23:4621000 4.6M, FY22:0 0.0M, FY21:37000 0.0M, FY20:63000 0.1M, FY19:23000 0.0M

Annual Profit FY23:3914000 3.9M, FY22:-110000 -0.1M, FY21:37000 0.0M, FY20:62000 0.1M, FY19:7000 0.0M

Annual Net worth FY23:-147740000 -147.7M, FY22:-69846000 -69.8M, FY21:-41357000 -41.4M, FY20:-37551000 -37.6M, FY19:-30634000 -30.6M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:2017000 2.0M, Q1/2025:0 0.0M, Q4/2023:null 0.0M, Q2/2023:null 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:2017000 2.0M, Q1/2025:null 0.0M, Q4/2023:-378000 -0.4M, Q2/2023:null 0.0M

Quarterly Net worth Q3/2025:-153358000 -153.4M, Q2/2025:-100784000 -100.8M, Q1/2025:-52370000 -52.4M, Q4/2023:-95787000 -95.8M, Q2/2023:null 0.0M

About ABIVAX S.A. & investment objective

Company Information ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

Organisation Biotechnology

Employees 67

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

ABIVAX S.A. FAQs

What is the share price of ABIVAX S.A. today?

The current share price of ABIVAX S.A. is $117.43.

Can I buy ABIVAX S.A. shares in India?

Yes, Indian investors can buy ABIVAX S.A. shares by opening an international trading and demat account with Motilal Oswal.

How to buy ABIVAX S.A. shares in India?

You can easily invest in ABIVAX S.A. shares from India by:

Can I buy fractional shares of ABIVAX S.A.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of ABIVAX S.A.?

ABIVAX S.A. has a market cap of $8187.96 M.

In which sector does ABIVAX S.A. belong?

ABIVAX S.A. operates in the Biotechnology sector.

What documents are required to invest in ABIVAX S.A. stocks?

To invest, you typically need:

What is the PE and PB ratio of ABIVAX S.A.?

The PE ratio of ABIVAX S.A. is N/A and the PB ratio is 16.50.